email other
Eisai support programs — authorization revocation correspondence
No phone listed for this route
Published hoursNot published in this record
Confirm the exact product or service
National contact — confirm product and location
Written revocation of the applicable LENVIMA or LEQEMBI Companion health-information authorization; not application intake, prescriptions, payments or the pharmacy location.
Current forms publish the same Suite 300 mailing destination for authorization revocation. Name the applicable program and follow its instructions. The forms also permit product-specific phone/fax contact through their respective enrollment contacts.
View source ↗ · Source checked 2026-10-22 · Matching authorization-revocation address on page 7 ↗
Report an update